Gene · 8650
Papers2,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | J Cell Sci | 2022 | 36398662 | PubTator, text mining | PubMed |
| Characterization of Two Novel EF-Hand Proteins Identifies a Clade of Putative Ca2+-Binding Protein Specific to the Ambulacraria. | J Bioinform Syst Biol | 2022 | 36382242 | PubTator, text mining | PubMed |
| The expression of ASAP3 and NOTCH3 and the clinicopathological characteristics of adult glioma patients. | Open Med (Wars) | 2022 | 36382054 | PubTator, text mining | PubMed |
| The role of altered microRNA expression in premalignant and malignant head and neck lesions with epithelial origin. | Health Sci Rep | 2022 | 36381409 | PubTator, text mining | PubMed |
| Chitinase-like protein 3: A novel niche factor for mouse neural stem cells. | Stem Cell Reports | 2022 | 36368330 | PubTator, text mining | PubMed |
| PI(4,5)P2: signaling the plasma membrane. | Biochem J | 2022 | 36367756 | PubTator, text mining | PubMed |
| Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. | Cells | 2022 | 36359888 | PubTator, text mining | PubMed |
| MicroRNAs' Crucial Role in Salivary Gland Cancers' Onset and Prognosis. | Cancers (Basel) | 2022 | 36358723 | PubTator, text mining | PubMed |
| RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway. | Cell Death Dis | 2022 | 36351890 | PubTator, text mining | PubMed |
| Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer. | Elife | 2022 | 36346211 | PubTator, text mining | PubMed |
| RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC. | Cancer Cell Int | 2022 | 36335386 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
Vacuolin-1 enhances RA-induced differentiation of human myeloblastic leukemia cells: evidence for involvement of a CD11b/FAK/LYN/SLP-76 axis subject to endosomal regulation that drives late differentiation steps. | Cell Biosci | 2022 | 36329484 | PubTator, text mining | PubMed |
| Non-coding RNAs and glioma: Focus on cancer stem cells. | Mol Ther Oncolytics | 2022 | 36321132 | PubTator, text mining | PubMed |
| DJExpress: An Integrated Application for Differential Splicing Analysis and Visualization. | Front Bioinform | 2022 | 36304260 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. | Pharmaceutics | 2022 | 36297643 | PubTator, text mining | PubMed |
| Lysosomes and Their Role in Regulating the Metabolism of Hematopoietic Stem Cells. | Biology (Basel) | 2022 | 36290314 | PubTator, text mining | PubMed |
| Implication of Adipogenesis-Coupled CRMP2 Functional Profile in Metabolic Homeostasis and Imbalance. | Biomedicines | 2022 | 36289868 | PubTator, text mining | PubMed |
| Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. | Biomedicines | 2022 | 36289620 | PubTator, text mining | PubMed |
| UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. | Oncogene | 2022 | 36273042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8650/papers?page=17